Tiny study probes how radiation wakes up immune cells in lung tumors
NCT ID NCT03603002
First seen Jun 26, 2026 · Last updated Jul 02, 2026 · Updated 2 times
Summary
This pilot study looked at how radiation therapy changes immune cells inside stage I lung cancer tumors. Researchers took biopsies before and after radiation to track T-cell changes and identify tumor antigens. Only 6 people took part, so the goal was to gather early data, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help researchers understand how radiation therapy triggers the immune system against lung cancer, potentially guiding future combination treatments.
- What could go wrong
- This is a very small pilot study with only 6 participants, so results may not apply broadly. It is designed to gather information, not to test a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER STAGE I are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Bayview Medical Center
Baltimore, Maryland, 21224, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Radiation and immunotherapy join forces against early lung cancer
- Inhaled therapy aims to cut lung Tumors' sugar supply
- Dye vs. air: which better guides lung cancer surgery?
- New combo therapy aims to stop lung cancer from returning
- Blood test guides new attack on lung cancer return
- No-Marker tumor tracking could make lung cancer radiation safer